Earnings Call · Q2 FY2024·2024-08-08

Q2 24EPS +25.00%·Rev n/aQ1 24EPS +25.93%·Rev n/aQ4 23EPS -27.27%·Rev n/aQ3 23EPS +50.00%·Rev n/a⚠ consensus missing

Elanco Animal Health Inc ELAN

Katy Grissom — Head of Investor Relations and ESG

Jeffrey Simmons — President and Chief Executive Officer

Todd Young — Chief Financial Officer

+4.9%1d on move date+2.6% vs SPY3d+5.7%5d+13.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ELAN calls or request research access.

More ELAN calls Browse calls Request research access